Primary Cutaneous B-Cell Non-Hodgkin Lymphoma: Clinical Trials

3 trials for Primary Cutaneous B-Cell Non-Hodgkin Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Primary Cutaneous B-Cell Non-Hodgkin Lymphoma: new trials by email Literature Review of Primary Cutaneous B-Cell Non-Hodgkin Lymphoma trials Research Report on Primary Cutaneous B-Cell Non-Hodgkin Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alisertib in Combination With Vorinostat in Treating Patients With Relapsed or Recurrent Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma, or Peripheral T-Cell Lymphoma
Alisertib, Laboratory Biomarker Analysis, Pharmacological Study - Adult B Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia
Phase 1CompletedNational Cancer Institute (NCI)342012-04-162018-04-11
Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancers
Laboratory Biomarker Analysis, Lenalidomide, Pharmacological Study - Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11
Phase 1CompletedNational Cancer Institute (NCI)172010-11-242017-09-25
Collecting and Storing Tissue Samples From Patients With Rare or Cutaneous Non-Hodgkin Lymphoma
Cytology Specimen Collection Procedure - Adult Immunoblastic Lymphoma, Central Nervous System Non-Hodgkin Lymphoma
CompletedChildren's Oncology Group1742005-05-302023-10-03

Narrower conditions

Leukemia, Lymphocytic, Chronic, B-Cell (3)  ·  Lymphoma, B-Cell, Marginal Zone (3)  ·  Lymphoma, Follicular (3)  ·  Lymphoma, Large-Cell, Immunoblastic (3)  ·  Lymphoma, Mantle-Cell (3)  ·  Lymphoma, Non-Hodgkin (3)  ·  Lymphoma, T-Cell, Cutaneous (3)  ·  Burkitt Lymphoma (2)  ·  Immunoblastic Lymphadenopathy (2)  ·  Intraocular Lymphoma (2)  ·  Leukemia, Hairy Cell (2)  ·  Leukemia, Large Granular Lymphocytic (2)  ·  Lymphoma, Large-Cell, Anaplastic (2)  ·  Lymphoma, T-Cell (2)  ·  Mycosis Fungoides (2)

Broader conditions

Chronic Disease (3)  ·  Disease Attributes (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, B-Cell (3)  ·  Leukemia, Lymphoid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoma (3)  ·  Lymphoma, B-Cell (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Pathologic Processes (3)

Interventions

Lenalidomide (1)  ·  MLN 8237 (1)  ·  Vorinostat (1)

Sponsors

National Cancer Institute (NCI) (2)  ·  Children's Oncology Group (1)

Countries

United States (3)  ·  Australia (1)  ·  Canada (1)  ·  Puerto Rico (1)

Top investigators

Amanda M Termuhlen (1)  ·  Leslie Andritsos (1)  ·  Tanya Siddiqi (1)

Results publications

PMID 31617432

NIH funding

P30CA016058 (1), P30CA033572 (1), U01CA062505 (1), U01CA076576 (1), U10CA098543 (1), UG1CA189958 (1), UM1CA186717 (1)